Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease.
Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- Ipilimumab (Yervoy)
You must log in to post a comment.